In this investigation, our objective is to devise a multi-epitope preventive vaccine targeting SARS-CoV-2 and dengue co-infection, constructed utilizing epitopes derived from three distinct SARS-CoV-2 antigens: spike, nucleocapsid, and membrane proteins, alongside one dengue genome polyprotein antigen. Here, CHMP5 is linked to dengue disease.